- About
- PsychU For You
- Topics
- Events
- Content
Request A Presentation
Request a free educational program for your organization or region today! These PsychU presentations are available both online and in-person, and cover a range of topics including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and more. Select one of the programs below to learn more about the objectives or to submit your request now.
-
Agitation & Alzheimer’s Disease (AAD)
(+)-
Agitation Associated With Alzheimer’s Dementia (AAD) In The Long-Term Care (LTC) Setting
-
The Agitation in Alzheimer’s Screener For Caregivers (AASC™) – A New Tool To Disease Recognition
-
Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)
-
-
Bipolar Disorder
(+)-
The Impact Of Adherence In Patients With Bipolar I Disorder
-
Strategies To Optimize Patient Outcomes In Bipolar-I Disorder: Role Of Long-Acting Injectable Antipsychotics
-
Clinical & Economic Impact Of Bipolar Disorder
-
Bipolar Disorder: Updates On Research & Clinical Outcomes
-
A Clinical Discussion Of Mixed States In Bipolar Disorder
-
Addressing Diagnostic Complexities Of Bipolar Disorder
-
Updates In Bipolar Disorder: Pathophysiology & Treatment Considerations
-
-
Digital
(+)-
DIGITAL MSL ONLY: Ask a Digital Navigator: Adopting Technology to Improve Mental Health
-
Digital Mental Health Treatments: The Role Of Neurobehavioral Therapies In MDD
-
Implementing Technology Into The Management Of Patients With Mental Health Disorder
-
Engaging Patients With Mental Health Disorders Through Technology
-
Use Of Telemedicine & Technology In The Treatment Of Mental Health
-
Neuromodulation Techniques: State Of The Science
-
-
Major Depressive Disorder (MDD)
(+)-
DIGITAL MSL ONLY: Let’s Face It, the Current Treatment Options for Depression Are Not Enough: Learn about Cognitive Emotional Training
-
Faces Of Depression In Primary Care: Depression Symptomology & Functional Outcomes From Early To Late Adulthood
-
Is It MDD Or Bipolar Disorder?
-
Proposed Roles Of Modulating Norepinephrine In Psychiatric Illnesses
-
Anxiety In Major Depressive Disorder
-
Monoamine Theory In Depression, Implications For Disease & Treatments
-
Considerations & Factors For Switching & Augmenting Medications For Major Depressive Disorder
-
Challenges & Opportunities For Comorbid Major Depressive Disorder (MDD) & Substance Use Disorder (SUD)
-
Impact Of Major Depressive Disorder On Patients, Caregivers, Payers & Employers
-
Recognizing & Responding To Inadequately Treated Major Depressive Disorder
-
Management Of Major Depressive Disorder: Breaking Through The Barriers
-
Inadequately Treated Major Depressive Disorder (MDD)
-
Mixicity In Depression: What Is It? & Why Is It Important For My Practice?
-
-
Other
(+)-
Improving Mental Health Care Together With PsychU
-
Suicide Awareness, Assessment & Prevention Strategies
-
Major Depressive Disorder In Chronic Kidney Disease
-
Motivational Interviewing
-
Sleep Impairment In Psychiatric Disorders
-
Mental Health Wellness: Addressing Health Care Professional (HCP) Burnout During Uncertain Times
-
PsychUsim: An Interactive & Innovative Journey For A Holistic Understanding Of Mental Illness
-
Pharmacokinetics: The Basics
-
Mindfulness Meditation In Mental Health
-
Collaborative Care In Mental Health
-
Born This Way? The Role Of Early Life Stress In Adult Mental Illness
-
The Aftermath Of Suicide: What Can Be Done & How Should We Talk About It?
-
Basics In Psychopharmacology
-
Metabolic Comorbidities In Major Depressive Disorder (MDD)
-
-
Population Health
(+)-
A Treatment Journey For Patients With Mental Health Illness – A Focus On The Jail System
-
Care Coordination For Adult Patients With SMI – From Inpatient To Outpatient
-
PsychU Improving Mental Health Care… Together
-
The Importance Of Population Health: A Mental Health Perspective
-
Social Determinants Of Health
-
The Importance Of Quality In Behavioral Health Care Measures, Programs & Insights
-
-
Post Traumatic Stress Disorder (PTSD)
(+)-
Exploring Post-Traumatic Stress Disorder: Treatment Landscape & Unmet Needs
-
PTSD Disease Burden: Patient, Humanistic, Clinical, & Economic Burden
-
PTSD: Epidemiology, Trauma Types, Risk Factors, Diagnosis, Clinical Presentation & Course
-
-
Schizophrenia
(+)-
Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment Of Schizophrenia
-
Initiating & Switching Antipsychotic Medications In Schizophrenia
-
Metabolic Wellness Considerations In Schizophrenia
-
Distinguishing Sedation From Efficacy In Antipsychotic Treatment
-
Antipsychotic Treatment Options In Schizophrenia
-
- PsychU For You
